Evidence map›Paper›PMID 16900393›Full record

ReviewJournal of mammary gland biology and neoplasia2005

Multifaceted role of Rho proteins in angiogenesis.

Sofia D Merajver, Saad Z Usmani

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 72 citations in OpenAlex.

  1. Resveratrol-induced SIRT1 activation inhibits glycolysis-fueled angiogenesis under rheumatoid arthritis conditions independent of HIF-1α.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Rac1, A Potential Target for Tumor Therapy.Frontiers in oncology · 2021
    Review
  7. Frontiers in cell and developmental biology · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Small Rho GTPases in the control of cell shape and mobility.Cellular and molecular life sciences : CMLS · 2014
    Review
  16. Article
  17. Review
  18. Article
  19. ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up.Cellular oncology (Dordrecht, Netherlands) · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sofia D MerajverBreast and Ovarian Cancer Risk Evaluation Program, University of Michigan Comprehensive Cancer Center, 7217 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0948, USA. smerajve@umich.edu
Saad Z Usmani
Beaumont Hospital, Dearborn · USMichigan Center for Translational Pathology · US

Funding

PREVENTION OF MAMMARY CANCER IN HER-2NEU TRANSGENIC MICER01CA077612 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MERAJVER, SOFIA DIANA · 1999 to 2007
$2.2M
NCI NIH HHS CA-77612
6 · The paper itself

Abstract

The Rho family of GTPases is part of the Ras superfamily. The Rho, Rac, and Cdc42 members of the family are present in mammalian cells and have been the subject of attention of researchers due to their vast spectrum of functions. Rac 1, Cdc42, and RhoA are well-known for their role in the regulation of the actin cytoskeleton in promoting the formation of lamellipodia, filopodia, and stress fibers, respectively. The Rho proteins also participate in the control of cell growth, motility, cell-cell adhesions, morphogenesis, cytoskeletal dynamics, and cellular trafficking. The mechanisms for eliciting these functions have become clearer during the last decade. Concordant with their roles in multiple processes of cellular control, the Rho proteins have been shown to be involved in tumor growth, progression, metastasis, and now angiogenesis.

Indexed as

Neovascularization, PathologicCell AdhesionCell MovementDisease ProgressionFibroblast Growth FactorsHumansInterleukin-6Interleukin-8Neoplasm MetastasisNeoplasmsrho GTP-Binding ProteinsThrombospondin 1Fibroblast Growth FactorsInterleukin-6Interleukin-8rho GTP-Binding ProteinsThrombospondin 1

Identifiers

PMID16900393
OpenAlexW2059481840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.